When routine analytical testing indicates that a sample contains elevated levels of arsenic, more detailed characterization is often warranted. Performing arsenic speciation analysis - where specific molecular forms of arsenic are individually quantified - is often critical; however, if you don't select the most appropriate analytical method, you can end up with without the data you need or paying too much for data that is not helpful. But with dozens of potential arsenic species and numerous analytical options available, deciding what analyses to request can sometimes seem overwhelming. Brooks Applied Labs has decades of experience offering advanced arsenic speciation services and can help you choose an appropriate approach to meet the objectives and budget of your project.

BAL's methods are predominantly based on ICP-MS technology so it should surprise no one that the Winter Conference on Plasma Spectrochemistry is one of the highlights of our year. This year's conference takes place February 3-8 in Pau, France, and Dr. Nausheen Sadiq will be presenting exciting new research on iodine isotopic ratio analysis in kelp samples. BAL's Dr. Hakan Gürleyük and CEO Michelle Briscoe will also be attending this year's conference. Please contact us if you will be attending and you'd like to connect, or if you would like more information about this new method!

Battelle's Conference on Remediation and Management of Contaminated Sediments will be held February 11-14 in New Orleans and BAL's  Dr. Stephen Springer and Jamie Fox will be attending . Stephen will be presenting a poster on an exciting new method that he developed for the determination of elemental mercury in soils. Please contact us if you will be attending or if you would like more information about this new method!

BAL's Business Development Director, Russ Gerads , will be attending the International Conference on Accelerating Biopharmaceutical Development in Carlsbad, CA from February 17-20. Schedule a meeting with Russ to learn more about our novel technologies for not just advancing biopharmaceutical development but achieving greater yield and reducing risk in your current operations through chemistry.